SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-291719
Filing Date
2020-11-12
Accepted
2020-11-12 16:25:59
Documents
2
Period of Report
2020-11-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d71631d8k.htm 8-K 17521
2 EX-99.1 d71631dex991.htm EX-99.1 52657
  Complete submission text file 0001193125-20-291719.txt   71289
Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39536 | Film No.: 201307119
SIC: 2836 Biological Products, (No Diagnostic Substances)